• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

GE HealthCare, Ulrich ink deal to offer multi-dose contrast media injector in U.S.

November 28, 2022 By Sean Whooley

GE Healthcare branded CT Motion injector
The CT Motion injector. [Image from GE HealthCare]
GE HealthCare today announced an agreement with Ulrich Medical to offer a GE HealthCare branded contrast media injector in the U.S.

The CT motion multi-dose syringeless injector delivers iodinated contrast media for computed tomography (CT) imaging procedures. It helps to reduce procedure setup time and increase patient throughput by eliminating time-consuming preparation steps. Additionally, it helps to optimize patient dosing and to reduce wasted contrast media.

According to a news release, recent research showed that CT motion could enable six additional CT exams each day. This could take place in a busy emergency department with up to three minutes saved per patient. Dr. Dushyant Sahani chair of radiology at the University of Washington, led and presented the research of more than 6,000 patients. It also demonstrated a reduction in cost from consumables and the saving of an average of 30 mL of contrast per procedure.

GE HealthCare continues to make moves around contrast media amid an ongoing supply chain shortage. Supply chain disruption related to contrast media caused thousands of Americans to have to wait for exams earlier this year. Earlier this month, the company announced an $80 million investment to expand contrast media production capacity in Norway. GE HealthCare said today that estimations project the contrast media injector market set to grow 4.3% annually between 2022-2030.

GE HealthCare expects demand to double

“Radiology departments are focused on managing increasing demand and on conserving contrast media,” said Marco Campione, Americas GM at GE HealthCare Pharmaceutical Diagnostics. “The CT motion supports efficient operational practices – saving time, saving contrast, saving on consumables, improving workflows and facilitates better patient throughput. We expect demand for iodinated contrast media to double in the next decade, so we are investing, both in production capacity expansion and also in technologies like this that conserve volumes and reduce leftover contrast media.”

Ulrich Medical CEO Klaus Kiesel added that GE HealthCare’s brand recognition and “great distribution power” can help expand the company’s market share on injectors.

“We are delighted to be working even more closely with our long-standing partner GE Healthcare, who have already been distributing our injector CT motion in the U.S. market,” said Kiesel.

Further efforts in the contrast media market

In addition to the Norway investment, GE HealthCare recently opened a $30 million manufacturing line in Cork, Ireland. It also announced a long-term agreement with Chile-based mining company SQM in October. That agreement secures its supply of iodine for vital imaging agents.

The company said it aims to produce 30 million more patient doses of iodinated contrast media annually by 2025.

GE HealthCare’s Pharmaceutical Diagnostics unit has all stages of its contrast media manufacturing managed entirely by the company. It features 4,000 employees globally and seven manufacturing sites.

Filed Under: Business/Financial News, Drug-Device Combinations, Imaging Tagged With: GE Healthcare, Ulrich Medical

IN CASE YOU MISSED IT

  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor
  • Medtronic to separate Diabetes business unit

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS